Reply to: Sustained resolutin of fibrosing cholestatic hepatitis C despite viremic relapse after stopping pegylated interferon and ribavirin therapy

被引:1
|
作者
Gopal, Deepak V. [1 ]
Rosen, Hugo R.
机构
[1] Univ Wisconsin, Div Gastroenterol & Hepatol, Madison, WI 53706 USA
[2] Univ Colorado, Div Gastroenterol & Hepatol, Denver, CO 80202 USA
[3] Univ Colorado, Hepatitis C Res Ctr, Denver, CO 80202 USA
关键词
D O I
10.1002/lt.21055
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:312 / 312
页数:1
相关论文
共 50 条
  • [1] Reply to: Sustained resolutin of Fibrosing cholestatic hepatitis C despite viremic relapse after stopping pegylated interferon and ribavirin therapy (vol 13, pg 312, 2007)
    Gopal, D., V
    Rosen, H. R.
    LIVER TRANSPLANTATION, 2007, 13 (04) : 630 - 630
  • [2] Sustained resolution of fibrosing cholestatic hepatitis C despite viremic relapse after stopping pegylated interferon and ribavirin therapy
    Bolkhir, Ahmed
    Brunt, Elizabeth M.
    Solomon, Harvey S.
    Hayashi, Paul H.
    LIVER TRANSPLANTATION, 2007, 13 (02) : 309 - 311
  • [3] Amelioration of Fibrosing Cholestatic Hepatitis after Stopping Pegylated Interferon and Ribavirin Therapy after Re-Transplantation for the Hepatitis C Liver Failure
    Kang, Koo Jeong
    Kim, Yong Hoon
    Kim, Hyung Tae
    Cho, Won Hyun
    Hwang, Jae Seok
    LIVER TRANSPLANTATION, 2010, 16 (06) : S181 - S181
  • [4] Kinetics of relapse after pegylated interferon and ribavirin therapy for chronic hepatitis C
    Brochot, Etienne
    Riachi, Ghassan
    Plantier, Jean-Christophe
    Guillemard, Catherine
    Vabret, Astrid
    Mathurin, Philippe
    Nguyen-Khac, Eric
    Duverlie, Gilles
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (07) : 1191 - 1198
  • [5] Successful treatment of fibrosing cholestatic hepatitis with pegylated interferon, ribavirin and sofosbuvir after a combined kidney-liver transplantation
    Delabaudiere, Cyrielle
    Lavayssiere, Laurence
    Doerr, Gaelle
    Muscari, Fabrice
    Danjoux, Marie
    Sallusto, Federico
    Peron, Jean Marie
    Bureau, Christophe
    Rostaing, Lionel
    Izopet, Jacques
    Kamar, Nassim
    TRANSPLANT INTERNATIONAL, 2015, 28 (02) : 255 - 258
  • [6] Relapse to opioid use after treatment of chronic hepatitis C with pegylated interferon and ribavirin
    Matthews, Annette M.
    Fireman, Marian
    Zucker, Betsy
    Sobel, Michelle
    Hauser, Peter
    AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (08): : 1342 - 1347
  • [7] Response of fibrosing cholestatic recurrent hepatitis C following liver transplantation to combination interferon/ribavirin therapy
    Lilly, Les
    Deschenes, Marc
    Marotta, Paul J.
    HEPATOLOGY, 2007, 46 (04) : 479A - 480A
  • [8] Delayed sustained virologic response after treatment of hepatitis C with pegylated interferon and ribavirin
    Yarze, Joseph C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S273 - S273
  • [9] Late relapse in chronic hepatitis C after sustained viral response to interferon and ribavirin
    Khokhar, N
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (04) : 471 - 472
  • [10] Autoimmune manifestation of hepatitis C virus infection as a risk for late virological relapse after pegylated interferon and ribavirin therapy
    Ruzic, Maja
    Fabri, Milotka
    Preveden, Tomislav
    Baculov, Katarina
    Pete, Maria
    Stojsin, Anja
    VOJNOSANITETSKI PREGLED, 2018, 75 (12) : 1233 - 1236